Stock Analysis

There May Be Some Bright Spots In Advanced Medical Solutions Group's (LON:AMS) Earnings

AIM:AMS
Source: Shutterstock

Investors were disappointed with the weak earnings posted by Advanced Medical Solutions Group plc (LON:AMS ). However, our analysis suggests that the soft headline numbers are getting counterbalanced by some positive underlying factors.

earnings-and-revenue-history
AIM:AMS Earnings and Revenue History March 28th 2025
Advertisement

The Impact Of Unusual Items On Profit

Importantly, our data indicates that Advanced Medical Solutions Group's profit was reduced by UK£11m, due to unusual items, over the last year. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. In the twelve months to December 2024, Advanced Medical Solutions Group had a big unusual items expense. As a result, we can surmise that the unusual items made its statutory profit significantly weaker than it would otherwise be.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Advanced Medical Solutions Group's Profit Performance

As we discussed above, we think the significant unusual expense will make Advanced Medical Solutions Group's statutory profit lower than it would otherwise have been. Because of this, we think Advanced Medical Solutions Group's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! On the other hand, its EPS actually shrunk in the last twelve months. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. For example, we've discovered 3 warning signs that you should run your eye over to get a better picture of Advanced Medical Solutions Group.

Today we've zoomed in on a single data point to better understand the nature of Advanced Medical Solutions Group's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About AIM:AMS

Advanced Medical Solutions Group

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.

Excellent balance sheet with reasonable growth potential.

Advertisement